![](https://endpts.com/wp-content/uploads/2024/07/Kevin-Finney.jpg)
Kevin Finney, Autobahn Therapeutics CEO
With new mission in psychiatry, Autobahn raises $100M to help back Phase 2 work
Autobahn Therapeutics’ journey through the clinic has been anything but speedy.
The ARCH-backed startup launched out of stealth more than four years ago in June …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.